Serotonergic and cholinergic interaction in the regulation of pituitary-adrenal function in rats
- 1 September 1985
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 41 (9) , 1123-1127
- https://doi.org/10.1007/bf01951690
Abstract
Summary It has been proposed that the central serotonergic inputs which modulate pituitary-adrenal secretion are mediated by cholinergic neurons. We have tested this hypothesis in intact rats. Male Sprague-Dawley rats were injected with cholinergic and serotonergic agents which enhanced transmitter function and with receptor blocking agents. Agents were injected, singly and in combination, into both unstressed and stressed animals. Since the response to cholinergic agents might be due to changes to vasopressin release, Brattleboro (vasopressin deficient) rats were also injected with cholinergic agents. The level of plasma corticosterone at 1-h post-injection was determined. Results indicate that the serotonin receptor blockade decreased the stimulatory, cholinergic effect of physostigmine. Cholinergic receptor blockers did not significantly reduce the corticosterone rise induced by 5-hydroxytryptophan. These results do not support the hypothesis of cholinergic mediation of serotonergic input. Nicotinic and muscarinic receptors appeared to exert opposing influences on the system. The nicotinic receptor antagonist was able to block the stimulatory effect of physostigmine. The muscarinic receptor antagonist significantly elevated plasma corticosterone levels. No differences were found in the effect of physostigmine on Brattleboro rats as compared to controls. These data are interpreted as suggesting that 1) the acetylcholine-induced stimulation of pituitary-adrenal function is mediated, in part, by serotonergic neurons; and 2) stimulation of nicotinic receptors is facilitatory whereas stimulation of muscarinic receptors is inhibitory to pituitary-adrenal function.Keywords
This publication has 25 references indexed in Scilit:
- THE DISCOVERY OF THE BRATTLEBORO RAT, RECOMMENDED NOMENCLATURE, AND THE QUESTION OF PROPER CONTROLS*Annals of the New York Academy of Sciences, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Comparison of Brainstem and Adrenal Circadian Patterns of Epinephrine SynthesisNeuroendocrinology, 1981
- Mood and Behavioral Effects of Physostigmine on Humans Are Accompanied by Elevations in Plasma β-Endorphin and CortisolScience, 1980
- The Effect of Quipazine, A Serotonin Receptor Agonist, on Serum Corticosterone Concentration in RatsEndocrine Research Communications, 1978
- Effect of quipazine on rat plasma prolactin levelsLife Sciences, 1976
- Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in ratsLife Sciences, 1976
- Serotonin and the regulation of the pituitary-adrenal system after deafferentation of the hypothalamusBrain Research, 1972
- EFFECTS ON ACTH RELEASE OF INTRAPITUITARY INJECTIONS OF POSTERIOR PITUITARY HORMONES AND SEVERAL AMINES IN THE HYPOTHALAMUSThe Japanese Journal of Physiology, 1968
- EFFECT OF ESERINE AND ATROPINE ON ADRENOCORTICAL HORMONE SECRETION IN UNANAESTHETIZED DOGSJournal of Endocrinology, 1964